| Date |
Time |
Source |
Heading |
|---|
| 21/11/2023 | 09:15 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 18/11/2023 | 08:15 | EDGAR2 | Form 8-K - Current report |
| 15/11/2023 | 08:35 | GLOBE | ZyVersa Therapeutics Reports Third Quarter 2023 Corporate.. |
| 09/11/2023 | 23:35 | GLOBE | ZyVersa Therapeutics Announces Article Published in.. |
| 06/11/2023 | 23:05 | GLOBE | ZyVersa Therapeutics Announces Article in Peer-Reviewed.. |
| 03/11/2023 | 07:37 | EDGAR2 | Form 8-K - Current report |
| 01/11/2023 | 23:07 | GLOBE | ZyVersa Therapeutics Announces Publication in Molecular.. |
| 25/10/2023 | 21:50 | GLOBE | ZyVersa Therapeutics Announces Research Published in the.. |
| 25/10/2023 | 07:15 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 23/10/2023 | 15:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
| 18/10/2023 | 22:05 | GLOBE | ZyVersa Therapeutics Announces a Publication in the.. |
| 18/10/2023 | 07:15 | EDGAR2 | Form S-1/A - General form for registration of securities.. |
| 11/10/2023 | 22:05 | GLOBE | ZyVersa Therapeutics Announces Peer-Reviewed Publication in.. |
| 04/10/2023 | 22:05 | GLOBE | ZyVersa Therapeutics Announces New Peer-Reviewed Publication.. |
| 27/9/2023 | 21:07 | GLOBE | ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate.. |
| 22/9/2023 | 20:35 | GLOBE | ZyVersa Therapeutics Announces Research Published in The.. |
| 21/9/2023 | 07:15 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
| 14/9/2023 | 21:00 | EDGAR2 | Form 8-K - Current report |
| 14/9/2023 | 06:57 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
| 14/9/2023 | 06:40 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 12/9/2023 | 20:30 | GLOBE | ZyVersa Therapeutics Announces Research Published in.. |
| 09/9/2023 | 06:20 | EDGAR2 | Form 8-K - Current report |
| 02/9/2023 | 06:45 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
| 22/8/2023 | 06:15 | GLOBE | ZyVersa Therapeutics Reports Second Quarter 2023 Corporate.. |
| 22/8/2023 | 06:03 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 19/8/2023 | 06:13 | EDGAR2 | Form 8-K - Current report |
| 15/8/2023 | 22:26 | EDGAR2 | Form NT 10-Q - Notification of inability to timely file Form.. |
| 03/8/2023 | 21:49 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 27/7/2023 | 07:27 | EDGAR2 | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 27/7/2023 | 07:11 | EDGAR2 | Form 8-K - Current report |
| 27/7/2023 | 06:21 | EDGAR2 | Form POS EX - Post-effective amendment adding exhibits to.. |
| 24/7/2023 | 22:00 | GLOBE | ZyVersa Therapeutics, Inc. Announces Pricing of $2.1 Million.. |
| 17/7/2023 | 21:38 | GLOBE | ZyVersa Therapeutics Announces Publication in the Journal,.. |
| 14/7/2023 | 21:37 | GLOBE | ZyVersa Therapeutics' CEO, Stephen C. Glover, Is an Invited.. |
| 10/7/2023 | 21:37 | GLOBE | ZyVersa Therapeutics Announces Publication in the Journal.. |
| 08/7/2023 | 05:44 | EDGAR2 | Form S-1/A - General form for registration of securities.. |
| 07/7/2023 | 21:37 | GLOBE | European Patent Granted for ZyVersa Therapeutics' Lead.. |
| 01/7/2023 | 07:01 | EDGAR2 | Form S-1/A - General form for registration of securities.. |
| 28/6/2023 | 21:37 | GLOBE | ZyVersa Therapeutics Announces Publication in Clinical.. |
| 21/6/2023 | 06:07 | GLOBE | ZyVersa Therapeutics Announces a Publication in Journal of.. |
| 13/6/2023 | 22:07 | GLOBE | ZyVersa Therapeutics Publishes New White Paper Detailing the.. |
| 06/6/2023 | 23:07 | GLOBE | European Patent Office to Grant ZyVersa Therapeutics’ Patent.. |
| 25/5/2023 | 23:07 | GLOBE | ZyVersa Therapeutics Announces a Publication in Frontiers in.. |
| 20/5/2023 | 06:15 | GLOBE | ZyVersa Therapeutics Announces Changes to ZyVersa’s Board of.. |
| 15/5/2023 | 23:07 | GLOBE | ZyVersa Therapeutics Announces Article Published in.. |
| 12/5/2023 | 23:07 | GLOBE | ZyVersa Therapeutics Reports First Quarter 2023 Corporate.. |
| 11/5/2023 | 23:07 | GLOBE | ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate.. |
| 09/5/2023 | 23:05 | GLOBE | ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate.. |
| 04/5/2023 | 23:07 | GLOBE | ZyVersa Therapeutics Announces a Publication in Hepatology.. |
| 02/5/2023 | 08:30 | GLOBE | ZyVersa Therapeutics, Inc. Announces Closing of $11.0.. |
Register to chat with like-minded investors on our interactive forums.
